disease-modifying therapy
C7044
concept
A disease-modifying therapy is a treatment that alters the underlying course or mechanisms of a disease to slow its progression, reduce long-term damage, or change its overall outcome rather than just alleviating symptoms.
All labels observed (6)
| Label | Occurrences |
|---|---|
| targeted cancer therapy | 13 |
| disease-modifying therapy canonical | 5 |
| disease-modifying antirheumatic drug | 2 |
| transthyretin-directed therapy | 2 |
| asthma maintenance therapy | 1 |
| disease-modifying therapy for spinal muscular atrophy | 1 |
Description generation (CDg)
The one-sentence description above was generated by prompting gpt-5.1 with the class name and this instruction.
Instruction
generate a one-sentence description for a given conceptual class. # Response Format Return only the sentence: "Description: [one-sentence description of the conceptional class]"
Input
Class: disease-modifying therapy
Generated description
A disease-modifying therapy is a treatment that alters the underlying course or mechanisms of a disease to slow its progression, reduce long-term damage, or change its overall outcome rather than just alleviating symptoms.
Instances (24)
| Instance | Via concept surface |
|---|---|
| risdiplam | disease-modifying therapy for spinal muscular atrophy |
| Tegsedi | transthyretin-directed therapy |
| methotrexate | disease-modifying antirheumatic drug |
| Plegridy | — |
| Tecfidera | — |
| Amvuttra | transthyretin-directed therapy |
| Tagrisso | targeted cancer therapy |
| Lynparza | targeted cancer therapy |
| Symbicort | asthma maintenance therapy |
| Imbruvica | targeted cancer therapy |
| fingolimod | — |
| ocrelizumab | — |
| larotrectinib | targeted cancer therapy |
| selpercatinib | targeted cancer therapy |
| LOXO-292 | targeted cancer therapy |
| Vitrakvi | targeted cancer therapy |
| Retevmo | targeted cancer therapy |
| Evrysdi | — |
| LOXO-195 | targeted cancer therapy |
| LOXO-305 | targeted cancer therapy |
| Gleevec | targeted cancer therapy |
| Venclexta | targeted cancer therapy |
| Alecensa | targeted cancer therapy |
| sulfasalazine | disease-modifying antirheumatic drug |